Metraipolis › archive › dc_0b72d644c736

Targeting Tumorigenic Coactivators in the PI3K/AKT Signaling Pathway: A Novel Approach for Cancer Treatment — Europe PMC PMID:41163374

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41163374
DOI
10.1002/cam4.71304
License (as archived)
solo-consultazione
Archived
2026-11-08T21:29:22.189Z
SHA-256 of the archived text
abbe395d35abf09c46da19643eb73a83da35f5b805427bd0dbcbcb9c9878fdd9
Stable URL of this page
https://metraipolis.com/documento/dc_0b72d644c736

How to cite

Targeting Tumorigenic Coactivators in the PI3K/AKT Signaling Pathway: A Novel Approach for Cancer Treatment — Europe PMC PMID:41163374 — Europe PMC (en), https://europepmc.org/article/MED/41163374 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0b72d644c736 (Metraipolis archive dc_0b72d644c736, sha256 abbe395d35abf09c46da19643eb73a83da35f5b805427bd0dbcbcb9c9878fdd9)
BibTeX
@misc{dc0b72d644c736,
  title = {Targeting Tumorigenic Coactivators in the PI3K/AKT Signaling Pathway: A Novel Approach for Cancer Treatment — Europe PMC PMID:41163374},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41163374},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0b72d644c736; sha256 abbe395d35abf09c46da19643eb73a83da35f5b805427bd0dbcbcb9c9878fdd9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41163374. Agents can read the archived copy with the MCP tool read_document.